Stromal expression of microRNA-21 identifies high-risk group in triple negative breast cancer

被引:0
|
作者
MacKenzie, Todd [1 ]
Schwartz, Gary [1 ]
Wells, Wendy [1 ]
Sempere, Lorenzo [2 ]
机构
[1] Dartmouth Hitchcock Med Ctr, Lebanon, NH 03766 USA
[2] Geisel Sch Med Dartmouth, Hanover, NH USA
关键词
D O I
10.1158/1538-7445.CHTME14-A67
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A67
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Stromal Expression of miR-21 Identifies High-Risk Group in Triple-Negative Breast Cancer
    MacKenzie, Todd A.
    Schwartz, Gary N.
    Calderone, Heather M.
    Graveel, Carrie R.
    Winn, Mary E.
    Hostetter, Galen
    Wells, Wendy A.
    Sempere, Lorenzo F.
    AMERICAN JOURNAL OF PATHOLOGY, 2014, 184 (12): : 3217 - 3225
  • [2] microRNA expression and recurrence risk prediction in Triple Negative Breast Cancer patients
    AbdulAziz, AhamdAizat
    MdSalleh, MdSalzihan
    Mohamad, Ibtisam
    Bhavaraju, VenkataMuraliKrishna
    Gan, SiewHua
    Ankathil, Ravindran
    ANNALS OF ONCOLOGY, 2017, 28
  • [3] Effect of microRNA-21 blockade in human triple negative breast cancer allografts on progression and immune checkpoint proteins
    Jin, Yuan-Yuan
    Desai, Vilas Shivaji
    Castro, Miguel M.
    Mitchell, Edith P.
    Wickstrom, Eric
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [4] Stromal Expression of MicroRNA-21 in Advanced Colorectal Cancer Patients with Distant Metastases
    Lee, Kyu Sang
    Nam, Soo Kyung
    Koh, Jiwon
    Kim, Duck-Woo
    Kang, Sung-Bum
    Choe, Gheeyoung
    Kim, Woo Ho
    Lee, Hye Seung
    JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE, 2016, 50 (04) : 270 - 277
  • [5] Leveraging cryoablation and checkpoint inhibitors for high-risk triple negative breast cancer
    de Miranda, Flavia Sardela
    Castro, Maribel
    Remmert, Nicole
    Singh, Sharda P.
    Rahman, Rakhshanda Layeequr
    Melkus, Michael W.
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [6] MicroRNA and triple negative breast cancer
    Yi, Bin
    Ma, Ruixia
    Xi, Yaguang
    CANCER RESEARCH, 2018, 78 (13)
  • [7] Interaction Between Beta-Catenin and EGFR Expression by Immunohistochemistry Identifies Prognostic Subgroups in Early High-risk Triple-negative Breast Cancer
    Lakis, Sotirios
    Dimoudis, Stefanos
    Kotoula, Vassiliki
    Alexopoulou, Zoi
    Kostopoulos, Ioannis
    Koletsa, Triantafyllia
    Bobos, Mattheos
    Timotheadou, Eleni
    Papaspirou, Irene
    Efstratiou, Ioannis
    Aravantinos, Gerasimos
    Karavasilis, Vasilios
    Zagouri, Flora
    Gogas, Helen
    Razis, Evangelia
    Pentheroudakis, George
    Christodoulou, Christos
    Pectasides, Dimitrios
    Fountzilas, George
    ANTICANCER RESEARCH, 2016, 36 (05) : 2365 - 2378
  • [8] Alteration in the expression of microRNA-21 regulated target genes: Role in breast cancer
    Thakur, Priyanka
    Saini, Reena, V
    Chhillar, Anil K.
    Saini, Neeraj K.
    Thakur, Vijay Kumar
    Siwal, Samarjeet Singh
    Saini, Adesh K.
    BIOCELL, 2022, 46 (02) : 309 - 324
  • [9] Serum microRNA-21 expression as a prognostic and therapeutic biomarker for breast cancer patients
    Yadav, Prasant
    Mirza, Masroor
    Nandi, Kajal
    Jain, S. K.
    Kaza, R. C. M.
    Khurana, Nita
    Ray, P. C.
    Saxena, Alpana
    TUMOR BIOLOGY, 2016, 37 (11) : 15275 - 15282
  • [10] MicroRNA-21 as an Indicator of Aggressive Phenotype in Breast Cancer
    Ozgun, Alpaslan
    Karagoz, Bulent
    Bilgi, Oguz
    Tuncel, Tolga
    Baloglu, Huseyin
    Kandemir, Emin G.
    ONKOLOGIE, 2013, 36 (03): : 115 - 118